Device Trial Radar · NCT02309736
OTX-14-002: Device Exposure Registry
Last checked: Nov 20, 2026Latest source record: Feb 5, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Not stated
Primary completion
Apr 2020
Sponsor
- Lead sponsor
- Ocular Therapeutix, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 5, 2014
Design
- Study type
- Observational
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of the study is to collect post-approval data relative to the incidence of endophthalmitis for cataract surgery patients treated with the FDA-approved ReSure Sealant when used by a broad group of physicians under commercial use conditions
Conditions
- Endophthalmitis
Interventions
ReSure SealantDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Occurrence of endophthalmitisTime frame: Day 30
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.